Our TK/GCV-suicide-gene system can selectively eradicate SOX2/OCT4-overexpressing CSCs in developing tumors, allowing us to evaluate how CSCs in their native tumor microenvironment contribute to tumor initiation and progression and responses to therapy. Here, SOX2 is linked to neoplasm.